HANNAH GUTHREY: Open Payments
NPI 1720849847 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,664 in 91 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,438 · 2025 $1,664
Food & beverage: $1,664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $319 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $309 |
| Janssen Biotech, Inc. | 15 | $295 |
| Regeneron Healthcare Solutions, Inc. | 4 | $126 |
| GENZYME CORPORATION | 3 | $92 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Madrigal Pharmaceuticals | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 6 | $59 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
Products named: TREMFYA, XIFAXAN, DUPIXENT, RINVOQ, LINZESS, RELISTOR, REZDIFFRA, CREON.
Industry payments across AR — which companies pay providers there.
